356 related articles for article (PubMed ID: 10643698)
21. Macrophage inflammatory protein-1 beta: a C-C chemokine in osteoarthritis.
Koch AE; Kunkel SL; Shah MR; Fu R; Mazarakis DD; Haines GK; Burdick MD; Pope RM; Strieter RM
Clin Immunol Immunopathol; 1995 Dec; 77(3):307-14. PubMed ID: 7586741
[TBL] [Abstract][Full Text] [Related]
22. Expression of CD 21, CD 22, and the mouse erythrocyte receptor on peripheral B lymphocytes in rheumatoid arthritis.
Hildebrandt S; von der Heydt I; von Wichert P
Ann Rheum Dis; 1988 Jul; 47(7):588-94. PubMed ID: 2969703
[TBL] [Abstract][Full Text] [Related]
23. Basophil activation by members of the chemokine superfamily.
Dahinden CA; Krieger M; Brunner T; Bischoff SC
Adv Exp Med Biol; 1993; 351():99-110. PubMed ID: 7524286
[No Abstract] [Full Text] [Related]
24. Identification and characterization of a promiscuous chemokine-binding protein in a human erythroleukemic cell line.
Horuk R; Wang ZX; Peiper SC; Hesselgesser J
J Biol Chem; 1994 Jul; 269(26):17730-3. PubMed ID: 7517400
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of synovial fluid T cell proliferation by anti-CD5 monoclonal antibodies. A potential mechanism for their immunotherapeutic action in vivo.
Verwilghen J; Kingsley GH; Ceuppens JL; Panayi GS
Arthritis Rheum; 1992 Dec; 35(12):1445-51. PubMed ID: 1282008
[TBL] [Abstract][Full Text] [Related]
26. Increased interleukin-26 in the peripheral joints of patients with axial spondyloarthritis and psoriatic arthritis, co-localizing with CD68-positive synoviocytes.
Hammitzsch A; Ossadnik A; Bachmann Q; Merwald-Fraenk H; Lorenz G; Witt M; Wiesent F; Mühlhofer H; Simone D; Bowness P; Heemann U; Arbogast M; Moog P; Schmaderer C
Front Immunol; 2024; 15():1355824. PubMed ID: 38799447
[TBL] [Abstract][Full Text] [Related]
27. Monocyte chemoattractant protein 1 and interleukin 8 production by rheumatoid synoviocytes. Effects of anti-rheumatic drugs.
Loetscher P; Dewald B; Baggiolini M; Seitz M
Cytokine; 1994 Mar; 6(2):162-70. PubMed ID: 8031999
[TBL] [Abstract][Full Text] [Related]
28. Amelioration of antigen-induced arthritis in rabbits treated with monoclonal antibodies to leukocyte adhesion molecules.
Jasin HE; Lightfoot E; Davis LS; Rothlein R; Faanes RB; Lipsky PE
Arthritis Rheum; 1992 May; 35(5):541-9. PubMed ID: 1374251
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-1 lymphocyte chemotactic activity in rheumatoid arthritis synovial fluid.
Miossec P; Dinarello CA; Ziff M
Arthritis Rheum; 1986 Apr; 29(4):461-70. PubMed ID: 3486662
[TBL] [Abstract][Full Text] [Related]
30. Citrullinated inter-alpha-trypsin inhibitor heavy chain 4 in arthritic joints and its potential effect in the neutrophil migration.
Osada A; Matsumoto I; Mikami N; Ohyama A; Kurata I; Kondo Y; Tsuboi H; Ishigami A; Sano Y; Arai T; Ise N; Sumida T
Clin Exp Immunol; 2021 Mar; 203(3):385-399. PubMed ID: 33238047
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of immune injury in rheumatoid arthritis: evidence for the involvement of T cells and heat-shock protein.
Strober S; Holoshitz J
Immunol Rev; 1990 Dec; 118():233-55. PubMed ID: 1967122
[TBL] [Abstract][Full Text] [Related]
32. Intramuscular gold decreases cytokine expression and macrophage numbers in the rheumatoid synovial membrane.
Yanni G; Nabil M; Farahat MR; Poston RN; Panayi GS
Ann Rheum Dis; 1994 May; 53(5):315-22. PubMed ID: 8017985
[TBL] [Abstract][Full Text] [Related]
33. Role for macrophage inflammatory protein 2 (MIP-2), MIP-1alpha, and interleukin-1alpha in the delayed-type hypersensitivity response to viral antigen.
Tumpey TM; Fenton R; Molesworth-Kenyon S; Oakes JE; Lausch RN
J Virol; 2002 Aug; 76(16):8050-7. PubMed ID: 12134010
[TBL] [Abstract][Full Text] [Related]
34. Cytolytic activity in T cell clones derived from human synovial rheumatoid membrane: inhibition by synovial fluid.
Miltenburg AM; Van Laar JM; De Kuiper P; Daha MR; Breedveld FC
Clin Exp Immunol; 1990 Dec; 82(3):499-503. PubMed ID: 2148285
[TBL] [Abstract][Full Text] [Related]
35. The role of tumour necrosis factor-alpha and IL-1 in polymorphonuclear leucocyte and T lymphocyte recruitment to joint inflammation in adjuvant arthritis.
Issekutz AC; Meager A; Otterness I; Issekutz TB
Clin Exp Immunol; 1994 Jul; 97(1):26-32. PubMed ID: 8033415
[TBL] [Abstract][Full Text] [Related]
36. Impaired interleukin-8-dependent chemotaxis by synovial fluid polymorphonuclear leukocytes in rheumatoid arthritis.
Hashimoto H; Yamamura M; Nishiya K; Ota Z
Acta Med Okayama; 1994 Aug; 48(4):181-7. PubMed ID: 7817772
[TBL] [Abstract][Full Text] [Related]
37. Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes.
Schall TJ; Bacon K; Camp RD; Kaspari JW; Goeddel DV
J Exp Med; 1993 Jun; 177(6):1821-6. PubMed ID: 7684437
[TBL] [Abstract][Full Text] [Related]
38. Chemotaxis of T lymphocytes on extracellular matrix proteins. Analysis of the in vitro method to quantitate chemotaxis of human T cells.
Taub DD; Key ML; Clark D; Turcovski-Corrales SM
J Immunol Methods; 1995 Aug; 184(2):187-98. PubMed ID: 7544817
[TBL] [Abstract][Full Text] [Related]
39. Immunoregulatory lymphokines in rheumatoid joints. III. B cell growth promoting activity of cells eluted from rheumatoid synovial tissue.
Hovdenes J; Lund H; Lea T; Egeland T
Scand J Rheumatol; 1988; 17(5):371-8. PubMed ID: 3264935
[TBL] [Abstract][Full Text] [Related]
40. Anti-TNF therapy reduces serum levels of chemerin in rheumatoid arthritis: a new mechanism by which anti-TNF might reduce inflammation.
Herenius MM; Oliveira AS; Wijbrandts CA; Gerlag DM; Tak PP; Lebre MC
PLoS One; 2013; 8(2):e57802. PubMed ID: 23460910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
